Nipent and anaemia Patient Reports February 13, 2012

Nipent Side Effects Report #4949394-9
Nipent side effect was reported by a Physician from PUERTO RICO on Mar 03, 2006. Female patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: anaemia, enteritis, herpes zoster, leukopenia, lymphadenopathy, neutropenia, upper respiratory tract infection. Nipent dosage: (1.25 MG/M2, DAY #2, 3, 4), INTRAVENOUS. During the same period patient was treated with RITUXIMAB, GEMCITABINE, NEULASTA. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #5835413-4
Nipent side effect was reported by a Health Professional from UNITED STATES on July 29, 2008. Female patient, 68 years of age, weighting 172.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: anaemia, cholecystitis, clostridium difficile colitis, rash pruritic. Nipent dosage: 7 MG Q21DAYS IV. During the same period patient was treated with CYTOXAN, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #5410293-X
Nipent side effect was reported by a Health Professional from UNITED STATES on July 27, 2007. Female patient, 62 years of age, weighting 179.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: anaemia, blood thyroid stimulating hormone increased, presyncope, syncope vasovagal, thrombocytopenia. Nipent dosage: 4 MG/M2 Q21DAYS. During the same period patient was treated with CYCLOPHOSPHAMID, RITUXAN, GLIPIZIDE, GLUCOPHAGE, ALLEGRA, ALLOPURINOL, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4919286-X
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2006. Male patient, 42 years of age, weighting 180.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: anaemia, aplasia pure red cell. Nipent dosage: 0.1905 MG/M2 (4 MG/M2, EVERY 3 WKS), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, ACYCLOVIR, BACTRIM. Patient was hospitalized. Patient recovered.